Chief Executive Officer
Tim joined Teligent Inc. as President and CEO in February 2020. He brings over 26 years of experience in the pharmaceutical industry, having held a variety of senior executive positions in general management, marketing and sales.
Prior to joining Teligent, Tim spent 16 years at Barr Laboratories, eventually serving as Executive Vice President, Global Generic Sales and Marketing where he led a team of nearly 2,000 employees in 25 countries. Subsequently, Tim held positions of Senior Vice President, Corporate Strategic Development at Mylan, and President, Retail Medicine at 1-800-Doctors, Inc.
Most recently, Tim served as Chief Executive Officer of Geritrex, LLC, a manufacturer and marketer of generic over the counter pharmaceuticals.
Tim holds a B.A. in Political Science from the University of Richmond.
General Manager, Estonia
Anneli joined Teligent in February 2016 as the General Manager of Estonia. She is responsible for the company’s startup in Estonia, which will include supply chain and quality operations support to the company’s suppliers and manufacturing partners around the world.
Prior to joining Teligent, Anneli managed the Transaction Services team at KPMG Estonia. She has more than 15 years of experience in management consulting, financial advisory, investor relations and M&A. Anneli has worked at Deloitte, the Estonian Energy Company and Trigon Capital, among other firms.
She graduated from Concordia International University with a BA in international business.
Vice President, Business Development
Eric joined Teligent in June 2016 as the Vice President of Business Development, where he leads the identification and development of new business opportunities, including acquisitions, licensing agreements, strategic alliances and new ventures.
Prior to joining Teligent, Eric served as Director of Global Business Development at Akorn, Inc. where he executed the Company’s business development strategy in generic and branded prescription pharmaceuticals, as well as in animal and consumer health products. Prior to Akorn, Eric held various roles at Baxter International Inc. in business development, strategy and commercial analytics. His background also includes over 10 years of healthcare investment management experience, including at Citadel LLC.
He holds an MS in Biotechnology from Northwestern University and a Bachelor’s degree in Chemistry and Anthropology from California State University, Fresno.
Directeur général, Canada
Mark s’est joint à Teligent en 2018 en tant que directeur général pour le Canada. Il est responsable de la mobilisation des clients, du développement des produits, de l’assurance de la qualité, des affaires réglementaires et d’établir notre vision. Il collabore activement avec nos partenaires fournisseurs et collègues européens pour stimuler l’intégration dans nos unités d’affaires.
Mark a acquis de l’expérience auprès de diverses industries, en travaillant chez Coca Cola, Campbells, Roche Diagnostics, Mylan Pharmaceuticals et a été tout dernièrement vice-président, Ventes et commercialisation chez Mint Pharmaceuticals.
Mark est un diplômé de l’Institut de technologie de la Colombie-Britannique avec un certificat en Gestion du marketing.
Chief Financial Officer
Damian joined Teligent, Inc. as the Chief Financial Officer in February 2018, after previously serving briefly on our Board of Directors in 2014. He leads the Finance, IT and Investor Relations teams.
Damian has over 25 years of Finance experience, most of which was spent in the pharmaceutical industry. He began his career in public accounting at KPMG LLP. Then, after spending nearly 14 years in a variety of roles at AstraZeneca, he served as VP Finance of Daiichi Sankyo Pharma Development, CFO of West-Ward Pharmaceuticals, SVP Finance of Heritage Pharmaceuticals and, most recently, as the CFO of Virtus Pharmaceuticals.
Damian has an undergraduate degree in Accounting from Penn State and an MBA from the University of Delaware.